Science and Enterprise

Month: November 2010

  • New Blood Test Indicates Heart Failure Potential

    Researchers at University of Maryland School of Medicine in Baltimore have developed a new investigative blood test that can help predict the risk of heart failure and cardiovascular death earlier than previously possible. The test is particularly useful in older people who do not have symptoms of heart failure. The new test measures troponin T,…

  • Report: U.S. Scientific Dominance Slipping

    A study from Thomson Reuters, Global Research Report: United States, released today (12 November), found that research output from the United States has been surpassed by that of Asia and Europe. The report is based on an analysis of research papers in the most influential journals, as indexed by Thomson Reuters in the Web of…

  • Vinegar-Lemon Compound Shown to Help Cure Organic Pork

    Makers of pork products who want to label their products as organic or natural are faced with a problem: two traditional curing agents for pork -– nitrites and nitrates -– aren’t allowed in natural and organic versions of the meat. Iowa State University (ISU) researcher Joe Sebranek, with support from the Food Safety Consortium, believes…

  • Company, Institute Collaborate on Targeted Drug Formulations

    Milestone Scientific Inc. in Livingston, New Jersey and Ordway Research Institute in Albany, New York have agreed to develop drug formulations for precise targeted delivery of drugs to affected body parts, organs, and cancerous tissue through Milestone’s CompuFlo injection technology. Milestone Scientific is a developer of computer-controlled drug delivery technologies and Ordway is a research…

  • Researchers Devise Formula to Calculate Walking Energy

    A university/government research team led by Peter Weyand of Southern Methodist University (SMU) in Dallas, Texas developed an equation to calculate exactly how much energy walkers expend based on walkers’ height, weight, and distance covered. Their findings and formula, which can be used in pedometers and biofeedback devices and for planning exercise regimens, are published…

  • Companies Partner on Renewable Fragrance/Flavor Materials

    Amyris Inc., a developer of renewable materials through synthetic biology in Emeryville, California said it has signed a collaboration and joint development agreement with Firmenich, a maker of fragrances and flavors in Geneva, Switzerland. This is the first agreement for Amyris in the fragrance and flavor industry. Firmenich will fund Amyris’s development of a sustainable…

  • Pre-Clinical Data Support Cancer Stem Cell Drug

    Geron Corporation in Menlo Park, California said today two studies with preclinical data demonstrate that the company’s telomerase inhibitor drug imetelstat (GRN163L) targets cancer stem cells from multiple myeloma, pancreatic, and breast cancers. Imetelstat is currently in Phase 2 clinical trials. The company says imetelstat targets cancer stem cells, found in many types of cancer,…

  • Semiconductor Group Signs Research Deal with Abu Dhabi

    Semiconductor Research Corporation (SRC) in Research Triangle Park, North Carolina and Advanced Technology Investment Company (ATIC) in Abu Dhabi announced today (11 November) a university research partnership to increase semiconductor R&D in the Arab Gulf state of Abu Dhabi. SRC is a university-industry research consortium for semiconductors and related technologies, and ATIC is a technology…

  • Small Business Grant Awarded for Helicopter R&D

    EMTEQ, an aviation engineering and avionics systems developer in New Berlin, Wisconsin, has received a Small Business Innovation Research (SBIR) grant from the U.S. Office of Naval Research for research on a lighting system for helicopter rotor blades. The award is part of the Department of Defense SBIR program, which devotes part of its R&D…

  • FDA Designates Orphan Drug Made From Tarantula Venom

    The U.S. Food and Drug Administration (FDA) has designated the peptide GsMTx4, made by Rose Pharmaceuticals of Buffalo, New York, as an orphan drug for Duchenne muscular dystrophy. Rose Pharmaceuticals is a one-year old company founded by University at Buffalo (UB) medical professor Frederick Sachs and Buffalo stockbroker Jeff Harvey. While Sachs (pictured left) applied…